Cart
sales@molnova.com
OSMI-4
CAS No. 2260791-14-6
OSMI-4( —— )
Catalog No. M33049 CAS No. 2260791-14-6
OSMI-4 is a low nanomolar O-GlcNAc transferase (OGT) inhibitor (EC50 of 3 μM in cells) that can be used to study OGT inhibition in different human cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 327 | Get Quote |
|
| 5MG | 511 | Get Quote |
|
| 10MG | 739 | Get Quote |
|
| 25MG | 1316 | Get Quote |
|
| 50MG | 2254 | Get Quote |
|
| 100MG | 2952 | Get Quote |
|
| 500MG | 3924 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOSMI-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionOSMI-4 is a low nanomolar O-GlcNAc transferase (OGT) inhibitor (EC50 of 3 μM in cells) that can be used to study OGT inhibition in different human cell lines.
-
DescriptionOSMI-4 is a low nanomolar O-GlcNAc transferase (OGT) inhibitor, with an EC50 of 3 μM in cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2260791-14-6
-
Formula Weight604.09
-
Molecular FormulaC27H26ClN3O7S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (103.46 mM; Ultrasonic )
-
SMILESCCOC(=O)CN(Cc1cccs1)C(=O)[C@H](NS(=O)(=O)c1cc2ccc(=O)[nH]c2cc1Cl)c1ccccc1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martin SES, et al. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors. J Am Chem Soc. 2018 Oct 24;140(42):13542-13545.?
molnova catalog
related products
-
Homo-VK-II-36
Homo-VK-II-36 is a carvedilol analogue that acts by inhibiting store-?overload-induced calcium release through the RyR2 channel.
-
Methyl 3-bromo-4,5-d...
Methyl 3-bromo-4,5-dihydroxybenzoate is a marine derived natural products found in Rhodomela confervoides.
-
MM-102 TFA
MM-102 TFA is a potent WDR5/MLL interaction inhibitor, achieves IC50 = 2.4 nM.?MM-102 compound prevents the interaction between mixed lineage leukemia 1 (MLL1) and WD Trp-Asp repeat domain 5 (WDR5) and results in the inhibition of MLL1 H3K4 histone methyltransferase (HMT) activity.
